Segment disclosures

Company overview

유바이오로직스

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 20 retained observations 14 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Consolidated

Consolidated And Separate Financial Statements

Source dimensions ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember
PeriodValueUnitFiledEvidence
2023-01-01 – 2023-12-3169365660612 KRW20240319Open filing evidence
2023-07-01 – 2023-09-3011432583121 KRW20231110Open filing evidence
2023-01-01 – 2023-09-3042472396944 KRW20231110Open filing evidence
2023-04-01 – 2023-06-3016645360571 KRW20230811Open filing evidence
2023-01-01 – 2023-06-3031039813823 KRW20230811Open filing evidence
2023-01-01 – 2023-03-3114394453252 KRW20230512Open filing evidence
2022-01-01 – 2022-12-3155466694236 KRW20240319Open filing evidence
2022-07-01 – 2022-09-3012762723633 KRW20231110Open filing evidence
2022-01-01 – 2022-09-3038046809949 KRW20231110Open filing evidence
2022-04-01 – 2022-06-3014562555282 KRW20230811Open filing evidence
2022-01-01 – 2022-06-3025284086316 KRW20230811Open filing evidence
2022-01-01 – 2022-03-3110721531034 KRW20230512Open filing evidence
2021-01-01 – 2021-12-3139384938147 KRW20240319Open filing evidence
2021-07-01 – 2021-09-3010824018258 KRW20221111Open filing evidence
2021-01-01 – 2021-09-3026959257222 KRW20221111Open filing evidence
2021-04-01 – 2021-06-308839255329 KRW20220816Open filing evidence
2021-01-01 – 2021-06-3016135238964 KRW20220816Open filing evidence
2021-01-01 – 2021-03-317295983635 KRW20220512Open filing evidence
2020-01-01 – 2020-12-3128489676012 KRW20230321Open filing evidence
2019-01-01 – 2019-12-3133072579699 KRW20220321Open filing evidence